117 Surgery vs botulinum for the impact of drooling on daily life in children with neurodevelopmental disabilities: a randomized controlled trial 5 Figure 2: The impact of drooling on daily care. BoNT-A, botulinum neurotoxin type A (n= 26); 2-DL, bilateral submandibular duct ligation (n= 27); * indicates statistical significance (p = <0·05) between baseline and follow-up; ** indicates statistical significance between BoNT-A and 2-DL (p = <0·05). Damage to electronics and/or furniture Damage to communication aids, electronic communication devices, computers, tablets and/or audio equipment caused by drooling was reported by 23% (6 of 26) of the caregivers before BoNT-A administration. Eight weeks thereafter, this rate dropped to 19% (5 of 26) while 32 weeks after injection 39% (10 of 26) of
RkJQdWJsaXNoZXIy MjY0ODMw